The Manual Oxygen Therapy System market is dominated by North America, accounting for 35% share, driven by advanced healthcare infrastructure, high adoption of innovative therapies, and robust government funding. The region’s mature ecosystem supports rapid integration of oxygen therapy systems in hospitals and home care settings. Asia Pacific, while currently at 25% share, is the fastest-growing region, fueled by rising chronic respiratory disease prevalence, expanding healthcare access in emerging economies, and increasing investments in medical infrastructure. Demographic shifts, including aging populations in Japan and China, further accelerate demand.